GlassScriptPhysician profile
Geetha Ajay
NPI 1235404443
$830.22
in general payments reported to CMS, 2019-2025
9 companies · $40.13 in 2025
The $40.13 reported for 2025 was less than what a typical School (Registered Nurse) provider received nationally (typical 2025 total: $120).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $151 · 2023: $563 · 2024: $76.05 · 2025: $40.13.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $679.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $679.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $386.00 | 2023-2025 | Wavewriter Alpha Prime 16, General - Pain Management |
| Kowa Pharmaceuticals America, INC. | $193.72 | 2023 | Seglentis |
| Azurity Pharmaceuticals, INC. | $65.26 | 2023-2024 | Horizant, Horizant |
| Horizon Therapeutics Plc | $62.77 | 2021 | |
| Collegium Pharmaceutical, INC. | $36.26 | 2021 | |
| Pfizer INC. | $29.45 | 2021 | |
| Medtronic, INC. | $22.50 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.72 | 2023 | Relistor |
| Metacel Pharmaceuticals LLC | $16.54 | 2023 | Ozobax |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Geetha Ajay listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.